Strategic IP holder Eris Innovations owns the intellectual property for Eris SOFR Swap futures and partners with exchanges to grow a broad suite of derivatives across asset classes. Sales opportunities exist in licensing additional IP, co-development with new exchanges, and expanding product reach to cover more currencies and tenors.

Clearing and access Eris SOFR Swap futures are listed and cleared at CME Group and are accessible wherever CME Group products are offered. This presents a cross-venue opportunity to upsell additional Eris products to existing CME Group counterparties and to exchanges seeking turnkey, cleared swap futures offerings.

Funding momentum Recent funding rounds totaling over seven million USD signal investor confidence and financial runway for product expansion and go-to-market efforts. Leverage this visibility to engage potential customers and partners with co-funded pilots, joint marketing, or accelerated product onboarding.

Market positioning Background as a leading alternative to traditional OTC swaps with a track record of launches and market data offerings like the Live Eris Swap Curve positions Eris as a knowledgeable partner for institutions seeking more transparent pricing, analytics, and liquidity access in interest rate derivatives.

Growth potential A small-to-mid sized team (11-50 employees) focused on product development and licensing indicates agility and niche specialization. This supports targeted outreach to mid-size buy-side firms, regional banks, and broker-dealers seeking innovative, efficiently integrated swap futures solutions.